Accéder au contenu
Merck

Identification of bioactive molecules by adipogenesis profiling of organic compounds.

The Journal of biological chemistry (2002-12-24)
Yongmun Choi, Yoshinori Kawazoe, Koji Murakami, Hiroyuki Misawa, Motonari Uesugi
RÉSUMÉ

An important step in the postgenomic drug discovery is the construction of high quality chemical libraries that generate bioactive molecules at high rates. Here we report a cell-based approach to composing a focused library of biologically active compounds. A collection of bioactive non-cytotoxic chemicals was identified from a divergent library through the effects on the insulin-induced adipogenesis of 3T3-L1 cells, one of the most drastic and sensitive morphological alterations in cultured mammalian cells. The resulting focused library amply contained unique compounds with a broad range of pharmacological effects, including glucose-uptake enhancement, cytokine inhibition, osteogenesis stimulation, and selective suppression of cancer cells. Adipogenesis profiling of organic compounds generates a focused chemical library for multiple biological effects that are seemingly unrelated to adipogenesis, just as genetic screens with the morphology of fly eyes identify oncogenes and neurodegenerative genes.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Chromeceptin, ≥98% (HPLC), solid